| Keyword search (4,030 papers available) | ![]() |
Author(s): Sanami S; Tremblay SA; Rezaei A; Potvin-Jutras Z; Sabra D; Intzandt B; Gagnon C; Mainville-Berthiaume A; Wright L; Gayda M; Iglesies-Grau J;...
Coronary artery disease (CAD), the leading cause of mortality worldwide, is increasingly recognized for its impact on brain health and cognition, yet the mechanisms linking CAD to vascular and meta...
Article GUID: 41452711
Author(s): Hervé V; KaAli OB; Benali H; Brouillette J;
Background: One of the main neuropathological hallmarks of Alzheimer's disease (AD) is the accumulation of amyloid-beta oligomers (Aßo), which begins in the brain approximately 15 years prior to the onset of clinical symptoms. Aßo-induced neuronal hyper...
Article GUID: 41436083
Author(s): Mitchell SW; Chan T; Trudel L; Hosseini SA; Macedo AC; Gonçalves MP; Rahmouni N; Hall BJ; Socualaya KMQ; Therriault J; Servaes S; Bezgin G; ...
Background: Brain and cognitive resilience (BR, CR) reflect the capacity to maintain structural integrity and cognitive function despite pathological tau deposition in Alzheimer's disease (AD)....
Article GUID: 41433447
Author(s): Gurve D; Centen AP; Slack PJ; Dang-Vu TT; Belleville S; Anderson ND; Montero-Odasso M; Nygaard HB; Chertkow H; Feldman HH; Brewster PWH; Lim...
Background: Older adults experience considerable day-to-day variability in cognitive function. We aimed to test the hypothesis that this is in part related to sleep, and determine which EEG sleep f...
Article GUID: 41434309
Author(s): Lamontagne-Kam D; Rahimabadi A; Bello DG; Lavallée-Beaulieu M; Fermawi AE; Bonenfant L; Nanci A; Benali H; Brouillette J;...
Background: Tau pathology is an important neuropathological marker of Alzheimer's Disease (AD) and correlates closely with neurodegeneration and cognitive decline. To date, much of the work exa...
Article GUID: 41435278
Author(s): Rousseau PN; Bazin PL; Steele CJ;
Article GUID: 41420671
Author(s): Kaeja M; Gajiyeva L; Iturria-Medina Y; Villringer A; Sehm B; Steele C;
Background: Stroke is a leading cause of death and disability, with proprioceptive impairments affecting up to 64% of survivors. These impairments hinder sensorimotor recovery, significantly impacting poststroke quality of life. Proprioception depends on an...
Article GUID: 41392885
Author(s): Chan V; Gausper A; Liu A; Andras LM; Illingworth KD; Skaggs DL; Imbeault R; Dufresne J; Parent S; Deschênes S; Roy-Beaudry M; Legler J; Benaroch L; Pirshahid AA; Serhan O; Cheng D; Bartley D; Carey...
Article GUID: 41386990
Author(s): Potvin-Jutras Z; Tremblay PL; Mohammadi H; Villeneuve S; Spreng RN; Gauthier CJ;
The apolipoprotein E4 (APOE4) allele is the strongest genetic risk factor for Alzheimer's disease (AD) and is linked to poorer cerebrovascular health. Cerebrovascular reactivity (CVR), an indicator of vascular reserve, and cerebral pulsatility (CP), a m...
Article GUID: 41353310
| Title: | The effects of a 12-week combined motor control exercise and isolated lumbar extension intervention on lumbar multifidus muscle stiffness in individuals with chronic low back pain |
| Authors: | Tornblom A, Naghdi N, Rye M, Montpetit C, Fortin M, |
| Link: | https://pubmed.ncbi.nlm.nih.gov/39258113/ |
| DOI: | 10.3389/fphys.2024.1336544 |
| Category: | |
| PMID: | 39258113 |
| Dept Affiliation: | SOH
1 Department of Health, Kinesiology and Applied Physiology, Concordia University, Montreal, QC, Canada. 2 School of Health, Concordia University, Montreal, QC, Canada. |
Description: |
Introduction: Exercise therapy is the primary endorsed form of conservative treatment for chronic low back pain (LBP). However, there is still conflicting evidence on which exercise intervention is best. While motor control exercise can lead to morphological and functional improvements of lumbar multifidus muscle in individuals with chronic LBP, the effects of exercise prescription on multifidus stiffness assessed via shear wave elastography are still unknown. The primary aim of this study is to determine the effects of a combined motor control and isolated lumbar extension (MC + ILEX) intervention on lumbar multifidus muscle stiffness. Methods: A total of 25 participants aged 18 to 65 were recruited from local orthopedic clinics and the university community with moderate to severe non-specific chronic LBP. Participants performed a 12-week MC + ILEX intervention program. Stiffness of the lumbar multifidus muscle (primary outcome) at L4 and L5 was obtained at baseline, 6-week, and 12-week using shear wave elastography. Changes in stiffness ratio (e.g., ratio of lumbar multifidus muscle stiffness from rest to contracted) were also assessed at both time points. Pre to post-intervention changes in lumbar multifidus muscle stiffness were assessed using a one-way repeated measure ANOVA. Results: Following the 12-week intervention, there were no statistically significant changes in lumbar multifidus muscle stiffness at rest on the right side at L4 (p = 0.628) and the left side at L4 and L5 (p = 0.093, p = 0.203), but a statistically significant decrease was observed on the right side at L5 (p = 0.036). There was no change in lumbar multifidus muscle stiffness ratio. Conclusion: This study provides preliminary evidence to suggest that a 12-week MC + ILEX intervention had minimal effect on lumbar multifidus muscle stiffness in individuals with chronic LBP. Further investigations are needed to confirm our findings and clarify the relationship between muscle stiffness and functional outcomes. |